Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04950075
Title Study of INBRX-109 in Conventional Chondrosarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Inhibrx, Inc.
Indications

chondrosarcoma

Therapies

INBRX-109

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.